30th Apr 2007 07:02
Oxford Biomedica PLC30 April 2007 Oxford BioMedica plc (the "Company") Director Shareholdings The Company received notification on 27 April 2007 that, on that day, Dr. SusanKingsman, a director of the Company and wife of Professor Alan Kingsman, ChiefExecutive Officer of the Company, sold 4,000,000 ordinary shares of 1p each inthe Company ("Ordinary Shares") at 48 pence per share. Following thistransaction, Dr. Kingsman is interested in 13,032,590 Ordinary Sharesrepresenting 2.44 per cent. of the Company's issued share capital. This includes8,293,451 Ordinary Shares held by Professor Alan Kingsman, 210,000 OrdinaryShares held jointly by Alan and Susan Kingsman and 100,000 Ordinary Shares heldby the son of Alan and Susan Kingsman. In addition, Andrew Wood and Peter Nolan, both Directors of the Company, havetoday exercised options over 167,000 and 132,000 Ordinary Shares in the Companyrespectively. Both directors have subsequently sold all of these Ordinary Sharesfor 48 pence per share. These shares were placed by Evolution Securities with institutional investors. Following these transactions, the total interests of Andrew Wood and Peter Nolanin the Company's Ordinary Shares and share options are as follows: +-----------------------+----------------------+-----------------------------+| |Ordinary Shares |Share Options |+-----------------------+----------------------+-----------------------------+|Andrew Wood |205,067 |1,428,923 |+-----------------------+----------------------+-----------------------------+|Peter Nolan |163,638 |906,162 |+-----------------------+----------------------+-----------------------------+ The exercise price for the options exercised today was 19.25p per share. Thenewly allotted shares are subject to a block listing, so are already listed.Including these shares, the total number of the Ordinary Shares in issue is now533,939,015. 30 April 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica